Prevalence Rates of Amyloid Positivity—Updates and Relevance

Young and Mormino discuss the prevalence rates of amyloid positivity. The field of biomarker research in Alzheimer disease (AD) has exploded over the past 2 decades, with tens of thousands of individuals undergoing characterization of amyloid burden with cerebrospinal fluid (CSF) and/or positron emi...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Archives of neurology (Chicago) 2022-03, Vol.79 (3), p.225-227
Hauptverfasser:	Young, Christina B, Mormino, Elizabeth C
Format:	Artikel
Sprache:	eng
Schlagworte:	Alzheimer's disease Amyloid Amyloid beta-Peptides Biomarkers Cerebrospinal fluid FDA approval Humans Neurodegenerative diseases Positron emission Positron emission tomography Prevalence Tomography
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!